67 related articles for article (PubMed ID: 16829029)
1. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B.
Serwin AB; Wasowicz W; Chodynicka B
Nutrition; 2006 Sep; 22(9):860-4. PubMed ID: 16829029
[TBL] [Abstract][Full Text] [Related]
2. Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes.
Scurt FG; Menne J; Brandt S; Bernhardt A; Mertens PR; Haller H; Chatzikyrkou C
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3753. PubMed ID: 38050450
[TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis?
Nowowiejska J; Baran A; Hermanowicz JM; Sieklucka B; Pawlak D; Flisiak I
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2217-2227. PubMed ID: 37568012
[TBL] [Abstract][Full Text] [Related]
4. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses.
Turker O; Kumanlioglu K; Karapolat I; Dogan I
J Endocrinol; 2006 Jul; 190(1):151-6. PubMed ID: 16837619
[TBL] [Abstract][Full Text] [Related]
5. Oral vitamin D
Ingram MA; Jones MB; Stonehouse W; Jarrett P; Scragg R; Mugridge O; von Hurst PR
J Dermatolog Treat; 2018 Nov; 29(7):648-657. PubMed ID: 29480035
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients.
Kharaeva Z; Gostova E; De Luca C; Raskovic D; Korkina L
Nutrition; 2009 Mar; 25(3):295-302. PubMed ID: 19041224
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFα treatment.
Skroza N; Proietti I; Bernardini N; La Viola G; Nicolucci F; Pampena R; Tolino E; Zuber S; Mancini MT; Soccodato V; Balduzzi V; Potenza C
G Ital Dermatol Venereol; 2013 Dec; 148(6):661-5. PubMed ID: 24442048
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial of the effect of monthly vitamin D supplementation in mild psoriasis
Jarrett P; Camargo CA; Coomarasamy C; Scragg R
J Dermatolog Treat; 2018 Jun; 29(4):324-328. PubMed ID: 28849682
[TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.
Groeger D; O'Mahony L; Murphy EF; Bourke JF; Dinan TG; Kiely B; Shanahan F; Quigley EM
Gut Microbes; 2013; 4(4):325-39. PubMed ID: 23842110
[TBL] [Abstract][Full Text] [Related]
10. The effect of supplementation with selenium and vitamin E in psoriasis.
Fairris GM; Lloyd B; Hinks L; Perkins PJ; Clayton BE
Ann Clin Biochem; 1989 Jan; 26 ( Pt 1)():83-8. PubMed ID: 2735752
[TBL] [Abstract][Full Text] [Related]
11. Dietary supplementation with very long-chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases.
Søyland E; Lea T; Sandstad B; Drevon A
Eur J Clin Invest; 1994 Apr; 24(4):236-42. PubMed ID: 8050452
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials.
Theodoridis X; Grammatikopoulou MG; Stamouli EM; Talimtzi P; Pagkalidou E; Zafiriou E; Haidich AB; Bogdanos DP
Nutrition; 2021 Feb; 82():111024. PubMed ID: 33183899
[TBL] [Abstract][Full Text] [Related]
13. Nutritional strategies for psoriasis: current scientific evidence in clinical trials.
Zuccotti E; Oliveri M; Girometta C; Ratto D; Di Iorio C; Occhinegro A; Rossi P
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8537-8551. PubMed ID: 30556896
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial.
Mayser P; Mrowietz U; Arenberger P; Bartak P; Buchvald J; Christophers E; Jablonska S; Salmhofer W; Schill WB; Krämer HJ; Schlotzer E; Mayer K; Seeger W; Grimminger F
J Am Acad Dermatol; 1998 Apr; 38(4):539-47. PubMed ID: 9555791
[TBL] [Abstract][Full Text] [Related]
15. Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris.
Antiga E; Bonciolini V; Volpi W; Del Bianco E; Caproni M
Biomed Res Int; 2015; 2015():283634. PubMed ID: 26090395
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: A Randomized Controlled Clinical Trial.
Navarro-López V; Martínez-Andrés A; Ramírez-Boscá A; Ruzafa-Costas B; Núñez-Delegido E; Carrión-Gutiérrez MA; Prieto-Merino D; Codoñer-Cortés F; Ramón-Vidal D; Genovés-Martínez S; Chenoll-Cuadros E; Pérez-Orquín JM; Picó-Monllor JA; Chumillas-Lidón S
Acta Derm Venereol; 2019 Nov; 99(12):1078-1084. PubMed ID: 31453631
[TBL] [Abstract][Full Text] [Related]
17. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions.
Dyring-Andersen B; Bonefeld CM; Bzorek M; Løvendorf MB; Lauritsen JP; Skov L; Geisler C
Scand J Immunol; 2015 Jul; 82(1):84-91. PubMed ID: 25904071
[TBL] [Abstract][Full Text] [Related]
18. Diet and physical exercise in psoriasis: a randomized controlled trial.
Naldi L; Conti A; Cazzaniga S; Patrizi A; Pazzaglia M; Lanzoni A; Veneziano L; Pellacani G;
Br J Dermatol; 2014 Mar; 170(3):634-42. PubMed ID: 24641585
[TBL] [Abstract][Full Text] [Related]
19. Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial.
Guida B; Napoleone A; Trio R; Nastasi A; Balato N; Laccetti R; Cataldi M
Clin Nutr; 2014 Jun; 33(3):399-405. PubMed ID: 24120032
[TBL] [Abstract][Full Text] [Related]
20. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study.
Søyland E; Funk J; Rajka G; Sandberg M; Thune P; Rustad L; Helland S; Middelfart K; Odu S; Falk ES
Br J Dermatol; 1994 Jun; 130(6):757-64. PubMed ID: 8011502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
